Day: April 28, 2020

ELMIRA, N.Y., April 28, 2020 (GLOBE NEWSWIRE) — Elmira Savings Bank (NASDAQ:ESBK) –HighlightsNet income was $1,018,000 for the three months ended March 31, 2020 compared to $927,000 for the same period in 2019.Diluted earnings per share were $.29 per share for the three months ended March 31, 2020 compared to $.26 per share for the same period in 2019. Return on average assets was .68% for the three months ended March 31, 2020 and .64% for the same period in 2019.Return on average equity was 6.93% for the three months ended March 31, 2020 compared to 6.41% for the same period in 2019.“We are pleased with the improvement in net income during the first quarter.  We are concerned about the current COVID-19 pandemic and the impact it is having on our economy, but feel fortunate that our market areas have not yet experienced the...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW.CALGARY, Alberta, April 28, 2020 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT) (“Sugarbud” or the “Company“) is pleased to announce that as part of the previously announced third-party licensing and distribution agreement with Agro-Greens Natural Products Ltd. it will officially launch its Craft Cannabis Collection of adult use recreational cannabis products on June 23, 2020. Sugarbud is also pleased to announce that it has filed and been receipted for a preliminary short-form prospectus with the securities regulatory authorities in all provinces of Canada (except Québec) in connection with a commercially...

SAN CARLOS, Calif., April 28, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc., (OTC: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the issuance of United States Patent No. 10,632,281, entitled “Drug Delivery Catheters that Attach to Tissue and Methods for Their Use.” This new patent provides additional, broad protection for the Helix™ Biotherapeutic Delivery System and covers the use of the helical needle delivery system with a deflectable guide catheter. The U.S. Patent Office has extended the life of this patent for 2.8 years beyond the usual 20-year term.Published literature has shown that the Helix System presents the lowest risk to patients for biotherapeutic delivery compared to other delivery methods evaluated,1 and is three to six times more efficient at...

Los Angeles, CA, April 28, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and unmanned vehicle sector (“UVS”), announced today that it will host a virtual-only shareholder update call on April 30, 2020 at 1PM PST/4PM EST.The shareholder update call will be facilitated by Draganfly CEO, Cameron Chell where management will provide a general update on the state of the industry, Draganfly’s current projects and future-state road map.Andy Card former White House Chief of Staff and current Draganfly board member will address the current global climate and the importance of the role and positioning of Draganfly. Dr. Jack Chow, Former...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, April 28, 2020 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RLTY.U) (OTC Pink: TDRYF) (“RWB” or the “Company”, formerly, Tidal Royalty Corp.) is pleased to announce the completion of its previously announced business combination (the “Transaction”) with MichiCann Medical Inc. d/b/a/ Red White & Bloom (“MichiCann”) pursuant to the terms of the Amended and Restated Business Combination Agreement dated March 12, 2020.As a result of the Transaction, the Company has changed its name to “Red White & Bloom Brands Inc.” and MichiCann is now a wholly-owned subsidiary of the Company. In connection with and immediately prior to the completion of the Transaction, the Company completed a share consolidation on...

                                           Kiadis Pharma to announce annual results for the year ended December 31, 2019 on Thursday April 30, 2020

                               Kiadis Pharma maakt donderdag 30 april 2020 de jaarcijfers bekend over het jaar eindigend op 31 december 2019

Invitation to conference call in connection with Sdiptech AB’s interim report for the first quarter of 2020Sdiptech will publish its interim report for the first quarter of 2020 on Wednesday, 29 April 2020 at 08:00 a.m. CET and invites you to a presentation via a webcast conference call on the same date at 09.30 a.m. CET. Sdiptech’s CEO Jakob Holm and CFO Bengt Lejdström will present the interim report and answer questions. The presentation will be held in English.Conference callThe presentation slides used will be available during the conference call and will be published on the company’s website, www.sdiptech.com, before the start of the presentation. To participate in the conference call, please use the following numbers,UK: + 44 333 300 9271US: + 1 833 526 8383Please ensure that you are connected to the conference...

Inbjudan till telefonkonferens i samband med Sdiptech AB (publ):s delårsrapport för första kvartalet 2020Sdiptech offentliggör sin delårsrapport för det första kvartalet 2020, onsdagen den 29 april 2020, kl. 08:00, och bjuder in till en presentation via en webbsänd telefonkonferens samma dag kl. 09.30. Sdiptechs VD Jakob Holm och CFO Bengt Lejdström kommer att presentera delårsrapporten samt svara på frågor. Presentationen hålls på engelska.TelefonkonferensDe presentationsbilder som används kommer att finnas tillgängliga under telefonkonferensen och kommer även att publiceras på bolagets hemsida, www.sdiptech.com, innan presentationen. För att delta i telefonkonferensen, var god använd följande nummer,SE: + 46 8 566 427 05UK: + 44 333 300 9271US: + 1 833 526 8383Presentationen webbsändsEn länk till Sdiptechs webcast kommer att finnas...

ACTON, Mass., April 28, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD) will hold its Annual Meeting of Stockholders (“Annual Meeting”) on Thursday, May 14, 2020 at 2:00 p.m. ET. The meeting, which will be held in a virtual format only, will be webcast to the public and can be accessed by going to http://www.psychemedics.com/proxy and following the instructions.Psychemedics Corporation has decided to hold the Annual Meeting in a virtual meeting format for this year, in light of public health concerns regarding the COVID-19 outbreak. We have designed the format of the Annual Meeting to ensure that stockholders are afforded the same rights and opportunities to participate as they would at an in-person meeting, using online tools along with telephone access to ensure stockholder access and participation.As described...